Home » Topics » BioWorld Science

BioWorld Science
RSS

Novartis synthesizes HIF-2alpha inhibitors

Nov. 24, 2021

Idorsia Pharmaceuticals patents CCR6 antagonists

Nov. 24, 2021

ALTA-002, a Toll-like receptor agonist antibody conjugate with promising antitumor activity in vivo

Nov. 24, 2021

GNE-502 shows promising efficacy in breast tumor xenograft model

Nov. 24, 2021

SNS-101, an anti-VISTA antibody, potentiates anti-PD-1/PD-L1 antitumor immunity

Nov. 24, 2021

Researchers develop a nonhuman primate model of Parkinson's disease

Nov. 24, 2021

Sanyou presents SYZJ-001 bispecific antibody drug against COVID-19

Nov. 23, 2021

Guard reports preclinical data on ROSgard in animal models of sepsis

Nov. 23, 2021

KAND-145 + cisplatin reduces tumor size in disease model of chemotherapy-resistant ovarian cancer

Nov. 23, 2021

Erythrocyte miR-210 as target for prevention of endothelial dysfunction in type 2 diabetes

Nov. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...